Health Care Related Organization – Page 60

Citizen Health Secures $14.5M in Seed Funding to Revolutionize Rare Disease Care with AI-Powered Data Platform

1 year ago talkbio0Tagged AI-Powered Data Platform, Chan, Citizen, Health, Health care facility, Initiative, Personalized, Rare Disease Care, Zuckerberg

Citizen Health, Rare Disease Care, AI-Powered Data Platform, Seed Funding, Chan Zuckerberg Initiative, Personalized Healthcare

Unlocking Health Equity: Leveraging Comprehensive SDOH Market Insights for Enhanced Treatment, Access, and Adherence

1 year ago talkbio0Tagged Adherence, Adherence (attribute), Data Analytics, Health care facility, Health Equity, Market, outcomes, public health medicine (field), Social Determinants of Health

Social Determinants of Health (SDOH), Health Equity, Market Insights, Treatment Access, Adherence, Healthcare Outcomes, Data Analytics, Public Health

Incyte’s $750M Acquisition Hits Roadblock: Key Trial Paused and Asset Cull Announced

1 year ago talkbio0Tagged asset, cull, Drug Industry, Incyte, News [Publication Type]

Incyte, $750M buyout, paused trial, asset cull, biotech news, pharmaceutical industry

Pharmaceutical Industry’s Digital Transformation Halted by Persistent Skills Shortage

1 year ago talkbio0Tagged Digital skills, digital transformation, Drug Industry, Pharma, skill, Talent Acquisition

Digital transformation in pharma, Skills shortage, Pharmaceutical industry challenges, Talent acquisition, Digital skills gap

Healthcare Evolution 2025: AI, IRA, and GLP-1s Redefine the Industry

1 year ago talkbio0Tagged advancements, Artificial Intelligence, Biopharma, DNA Integration, Glucagon-Like Peptide 1, Health care facility, Healthcare technology, Impact food supplement, Ira (eukaryote), Pharmaceutical Industry Shifts, Telemedicine, trends qualifier, Value-Based Care

AI in Healthcare, IRA Impact on Biopharma, GLP-1 Medications, Healthcare Trends 2025, Value-Based Care, Telemedicine Integration, Pharmaceutical Industry Shifts, Healthcare Technology Advancements

Rona’s Sanofi-Sourced siRNA Demonstrates Early Efficacy in Dyslipidaemia Treatment

1 year ago talkbio0Tagged development aspects, Dyslipidemias, Interferes with, Lipid Metabolism Disorders, RNA, RNA, Small Interfering, Rona, sanofi

siRNA, dyslipidaemia, Rona, Sanofi, RNA interference, lipid disorders, therapeutic development

Dupixent (Dupilumab) Advances Towards FDA Approval for Chronic Spontaneous Urticaria (CSU) in 2025

1 year ago talkbio0Tagged Biologic Medicine, Chronic Spontaneous Urticaria, dupilumab, Dupixent, Inflammation, Regeneron, Review [Publication Type], sanofi, United States Food and Drug Administration

Dupixent, Dupilumab, Chronic Spontaneous Urticaria (CSU), FDA Review, Sanofi, Regeneron, Biologic Medicine, Type 2 Inflammation, H1 Antihistamines

Gilead Sciences and Kite Pharma Announce Layoffs, Closure of Seattle and Philadelphia Offices

1 year ago talkbio0Tagged Gilead Sciences, Industry, Kite Pharma, Office Closures, Philadelphia, restructuring, Seattle

Gilead Sciences, Kite Pharma, layoffs, office closures, Seattle, Philadelphia, biotech industry, restructuring

Johnson & Johnson Expands Immunology Portfolio with $1.25B Acquisition of Yellow Jersey Therapeutics

1 year ago talkbio0Tagged Antibodies, Bispecific, Dermatitis, Atopic, Immunology, Johnson and Johnson, NM26, Numab, Yellow Jersey Therapeutics

Johnson & Johnson, Yellow Jersey Therapeutics, NM26, atopic dermatitis, bispecific antibody, immunology, Numab Therapeutics

Allogene Halts Leukemia CAR-T Trial Enrollment Due to Breyanzi Competition

1 year ago talkbio0Tagged Allogene, Breyanzi, CAR-T, cema-cel, Clinical Trials, leukemia, Myers, squibb

Allogene, CAR-T therapy, leukemia, Breyanzi, Bristol Myers Squibb, cema-cel, clinical trials